PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill.\', \'Eli Lilly and Co, Indianapolis, Indiana.\', \'New York University Langone Vaccine Center, Division of Infectious Diseases and Immunology, New York University Grossman School of Medicine, New York, New York.\', \'University of Illinois College of Medicine, Chicago.\', \'Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.\', \'Indiana University School of Medicine, Gary.\', \'Brengle Family Medicine, Indianapolis, Indiana.\', \'Division of Infectious Diseases, University of Colorado School of Medicine, Aurora.\', \'Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia.\', \'University of Nebraska Medical Center, Omaha.\', \'University of Cincinnati Academic Health Center, Cincinnati, Ohio.\', \'Florida Primary and Specialty Care, Boca Raton.\', \'Burke Internal Medicine & Research, Burke, Virginia.\', \'Division of Infectious Diseases, University of Louisville School of Medicine, Louisville, Kentucky.\', \'private practice, Huntington Beach, California.\', \'FHI 360, Durham, North Carolina.\', \'Louisiana State University Health Sciences Center, New Orleans.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jama.2021.8828
?:hasPublicationType
?:journal
  • JAMA
is ?:pmid of
?:pmid
?:pmid
  • 34081073
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all